Your browser doesn't support javascript.
loading
The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.
Monto, Arnold S; Zambon, Maria; Weir, Jerry P.
  • Monto AS; From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).
  • Zambon M; From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).
  • Weir JP; From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).
N Engl J Med ; 390(14): 1256-1258, 2024 Apr 11.
Article en En | MEDLINE | ID: mdl-38416423
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus de la Influenza B / Vacunas contra la Influenza / Gripe Humana Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus de la Influenza B / Vacunas contra la Influenza / Gripe Humana Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article